Search

To ensure greater access to cancer care for all New Yorkers and patients who come from around the globe, Memorial Sloan Kettering Cancer Center (MSK) today announced plans to build a new, state-of-the-art cancer care Pavilion on its main campus on the Upper East Side.

… Tuesday, March 15, 2022 To ensure greater access to cancer care for all New Yorkers and patients who come from around the globe, Memorial Sloan Kettering Cancer Center (MSK) today announced plans to build a new, state-of-the-art cancer care Pavilion on its main campus on the Upper East Side. The Centers

This article is Part 2 of our three-part series on MSK-led advances for improving outcomes for patients with rare head and neck cancers.

… Friday, March 22, 2024 Part 2: Rare Thyroid Cancers This article is Part 2 of our three-part series on MSK-led advances for improving outcomes for patients with rare head and neck cancers. Part 2 summarizes MSK’s leadership and expertise in developing new therapeutic options for patients with rare thyroid

A retrospective study from MSK has found that colorectal cancer patients with liver metastases live an average of two years longer when they receive an additional treatment called hepatic arterial infusion (HAI).

… Friday, April 21, 2017 Summary A retrospective study that looked at 20 years of data from MSK found that colorectal cancer patients with liver metastases live an average of two years longer when they receive an additional treatment called hepatic arterial infusion (HAI). Highlights When they metastasize

You may have read about a recent outbreak of mpox (formerly monkeypox), a virus typically found only in central and west Africa.

… Friday, June 24, 2022 There have been thousands of confirmed or suspected cases of mpox (formerly monkeypox) worldwide, including in the U.S. The virus is typically found only in central and west Africa. Mini Kamboj , Chief Medical Epidemiologist at Memorial Sloan Kettering (MSK), answers questions you

MSK researchers learn that some cancers may respond to checkpoint inhibitor drugs because of changes called gene fusions.

… Tuesday, April 30, 2019 Summary Research suggests that a type of genetic change called a gene fusion can send signals that the immune system can recognize. Findings from a single person with cancer can kick-start a major scientific breakthrough. When one person benefits from treatment in an uncommon

Study will be the first clinical trial testing an investigational stem cell therapy aimed at restoring lost brain cells called neurons in people with advanced Parkinson’s disease (PD).

… Friday, January 15, 2021 A recent approval from the U.S. Food and Drug Administration will allow MSK researchers and their collaborators to open the firstclinical trial testing an investigational stem cell therapy aimed at restoring lost brain cells called neurons in people with advanced Parkinson’s

A member of the Sloan Kettering Institute's Immunology Program and a Howard Hughes Medical Institute investigator, Alexander Rudensky is fascinated by how a specific type of white blood cells called regulatory T cells regulates our immune system.

… Friday, October 1, 2010 Summary A member of the Sloan Kettering Institute’s Immunology Program and a Howard Hughes Medical Institute investigator, Alexander Rudensky is fascinated by how a specific type of white blood cells called regulatory T cells regulates our immune system. A member of the Sloan

New MSK research finds a potential target against neuroendocrine transformation in lung and prostate cancers; discovers new clues about why donor T cells attack certain tissues in graft-versus-host disease; sheds light on why T cells let go of their prey; and uses CRISPR interference and dynamic cell-state transitions to discover enhancers that affect early human development.

… Thursday, August 10, 2023 New research from  Memorial Sloan Kettering Cancer Center (MSK)  and the  Sloan Kettering Institute  — a hub for basic science and translational research within MSK — found a potential target against neuroendocrine transformation in lung and prostate cancers; discovered n ew

A summer program offers college students from underrepresented communities a chance to get valuable research experience.

… Thursday, August 29, 2024 Every summer, curious college students have a chance to get a feel for what it’s like to be a cancer researcher. Memorial Sloan Kettering Cancer Center (MSK) chooses 10 students from underrepresented communities to participate in an 8-week internship called the Summer Clinical

Fred’s Team, MSK’s running program, has made history by surpassing $100 million in total funds raised for cancer research.

… Thursday, November 3, 2022 Fred’s Team, MSK’s running program, has made history by surpassing $100 million in total funds raised for cancer research. Since 1995, runners have joined Fred’s Team to add more meaning to their miles by raising money in support of lifesaving studies and clinical trials at